Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.97 USD
Change Today -0.36 / -3.86%
Volume 481.8K
AFFX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

3420 Central Expressway

Santa Clara, CA 95051

United States

Phone: 408-731-5000

Fax: 408-731-5380

ion, cytogenetic and genotyping analysis. It consists of instruments and consumables that provide for the robust preparation and analysis of samples using its GeneChip cartridge arrays. The components of the GeneChip system include disposable probe arrays containing genetic information on a chip, reagents for extracting, amplifying and labeling target nucleic acids, a fluidics station for introducing the test sample to the probe arrays, a hybridization oven for optimizing the binding of samples to the probe arrays, a scanner to read the fluorescent image from the probe arrays, and software to analyze and manage the resulting genetic information. GeneTitan The company’s GeneTitan instrument system runs genotyping and gene expression array plates in high throughput formats. The GeneTitan provides a hands-free, automated solution for monitoring gene expression and genome-wide SNP genotyping. QuantiGene Line of Low- to Mid-plex Products The company also offers its QuantiGene line of single plex and multiplex assays to serve customers in the research and translational medicine markets. Multiplex assays measure different targets from the same sample. These products enable drug target identification through analysis of gene silencing, cell signaling and biomarker validation. The company’s QuantiGene line of products is based on bDNA technology and delivers quantitative gene expression or DNA copy number analysis. The company also serves the needs of the molecular pathology market by enabling the highly sensitive measurement of RNA molecules in individual cells in tissue samples through its QuantiGene View RNA products. Life Science Reagents The company offers researchers a line of reagent kits, enzymes and biochemicals. The company’s reagents are complementary to its array portfolio, thus enabling the company to provide its customers with whole product solutions. In addition, they can be applied toof emerging technologies. The company’s reagents include the following: ExoSAP-IT For PCR Product Clean-Up, a reagent for the rapid clean-up of PCR products used in downstream applications, such as DNA sequencing or SNP analysis. HotStart-IT line of PCR reagents, reagents that utilize a novel primer binding protein to inhibit primer dimer formation, which results in sensitive and consistent amplification for real-time PCR assays. eBioscience Products eBioscience offers a portfolio of antibodies and reagents for use in flow cytometry. eBioscience is also a provider of multi-color flow cytometry reagents, a subsector of the of the global flow cytometry market. Within the immunoassays market, eBioscience offers a portfolio of simple, easy-to-use immunoassays kits for the quantitative measurement of either secreted or intracellular protein levels in biological samples, such as cell lysates or serum. These assays are in various single analyte and multiplex formats, including its rapidly growing Procarta Plex product line for multiplex immunoassays. eBioscience also develops and markets the QuantiGene line of low-to-mid-plex RNA and DNA measurement products. Services The company offers high-throughput genotyping services for customers using its genotyping products. Its projects range in size from a few hundred samples to approximately 100,000 samples. Sales and Distribution All of its business units sell their products through its Global Commercial Organization comprised of sales, field application and engineering support, and marketing personnel. The company markets and distributes its products directly to customers in North America, Japan and major European markets. In other markets, such as Mexico, India, Brazil, the Middle East and the Asia Pacific, including China, the company sells its products principally through third-party distributors that specialize in life science supply. The company maintains sales and distribution operations across the United States, Europe, Latin America and Asia. Strategy The company’s strategy has been to transform itself from one that is highly dependent on its GeneChip Expression product line that faces intense competition in certain applications, to one with

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $8.97 USD -0.36

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fluidigm Corp $11.58 USD -0.61
Foundation Medicine Inc $22.93 USD -0.61
Luminex Corp $17.71 USD -0.51
Sequenom Inc $2.05 USD -0.10
Takara Bio Inc ¥1,136 JPY -17.00
View Industry Companies
 

Industry Analysis

AFFX

Industry Average

Valuation AFFX Industry Range
Price/Earnings 43.0x
Price/Sales 2.1x
Price/Book 2.3x
Price/Cash Flow 39.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit www.affymetrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.